Ellomay Capital Past Earnings Performance
Past criteria checks 0/6
Ellomay Capital's earnings have been declining at an average annual rate of -24.3%, while the Renewable Energy industry saw earnings growing at 36% annually. Revenues have been growing at an average rate of 26.8% per year.
Key information
-24.3%
Earnings growth rate
-20.3%
EPS growth rate
| Renewable Energy Industry Growth | 36.0% |
| Revenue growth rate | 26.8% |
| Return on equity | -19.0% |
| Net Margin | -21.2% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Ellomay Capital makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 54 | -11 | 6 | 0 |
| 31 Mar 22 | 49 | -16 | 6 | 0 |
| 31 Dec 21 | 45 | -15 | 6 | 0 |
| 30 Sep 21 | 36 | -7 | 5 | 0 |
| 30 Jun 21 | 26 | -6 | 5 | 0 |
| 31 Mar 21 | 15 | -5 | 5 | 0 |
| 31 Dec 20 | 10 | -5 | 5 | 0 |
| 30 Sep 20 | 10 | 9 | 4 | 0 |
| 30 Jun 20 | 13 | 11 | 4 | 0 |
| 31 Mar 20 | 16 | 11 | 4 | 0 |
| 31 Dec 19 | 19 | 12 | 4 | 0 |
| 30 Sep 19 | 20 | -1 | 4 | 0 |
| 30 Jun 19 | 20 | -1 | 4 | 0 |
| 31 Mar 19 | 20 | 1 | 3 | 0 |
| 31 Dec 18 | 18 | 1 | 4 | 0 |
| 30 Sep 18 | 17 | -2 | 3 | 0 |
| 30 Jun 18 | 15 | -2 | 3 | 0 |
| 31 Mar 18 | 14 | -5 | 3 | 0 |
| 31 Dec 17 | 14 | -6 | 2 | 0 |
| 30 Sep 17 | 12 | -2 | 4 | 0 |
| 30 Jun 17 | 13 | -4 | 2 | 0 |
| 31 Mar 17 | 12 | 0 | 2 | 0 |
| 31 Dec 16 | 12 | 0 | 2 | 0 |
| 30 Sep 16 | 11 | -2 | 4 | 0 |
| 30 Jun 16 | 12 | 3 | 3 | 0 |
| 31 Mar 16 | 12 | 2 | 3 | 0 |
| 31 Dec 15 | 12 | 8 | 2 | 0 |
Quality Earnings: NUR is currently unprofitable.
Growing Profit Margin: NUR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NUR is unprofitable, and losses have increased over the past 5 years at a rate of 24.3% per year.
Accelerating Growth: Unable to compare NUR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NUR is unprofitable, making it difficult to compare its past year earnings growth to the Renewable Energy industry (41%).
Return on Equity
High ROE: NUR has a negative Return on Equity (-19.03%), as it is currently unprofitable.